Clinical Trials Directory

Trials / Unknown

UnknownNCT01415024

Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication

Resynchronization in Paced Heart Failure Patients With ICD Indication

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Schuechtermann-Klinik · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Today patients with a Cardiac Resynchronization Therapy (CRT) indication usually receive 2 ventricular leads, right ventricular (RV) apex and left ventricular (LV) (postero-) lateral, gaining a responder rate of approximately 70%. However, the physiological agitation of the left ventricle takes place over two pathways. Therefore single point stimulation might be insufficient for a dilated, insufficiently and asynchronously contracting left ventricle, resulting in either insufficient or no response to the therapy. In the "CRT ICD Dual LV" study the patients receive a second LV lead in an anterior vein. When this lead is placed, temporary dual LV stimulation is started. To assess the effectivity of the dual LV lead stimulation intraoperatively a LV dp/dt-pressure measurement is taken. If there is an increase in LV dp/dt, the patients will be stimulated with both leads permanently. If not they will be stimulated conventionally. The patients participating in this study are monitored for 12 months after implantation.

Conditions

Interventions

TypeNameDescription
PROCEDUREsecond LV lead in CRTsecond LV lead in CRT

Timeline

Start date
2011-05-01
Primary completion
2012-05-01
First posted
2011-08-11
Last updated
2011-08-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01415024. Inclusion in this directory is not an endorsement.